book a demo
On the one hand, networked medical devices are revolutionising the way patients engage with healthcare. On the other hand, these devices are exposing millions of patients and healthcare providers to safety and security risks.
While in the past the healthcare industry focused largely on patient privacy, it is important to note that security is not the same as privacy. Privacy focuses more on access control, while security is about protecting the systems and sensitive data from intruders.
Many healthcare records and devices in use today are vulnerable, and the number of networked medical devices is rapidly growing. As more connected devices come to the market, the following security risks must be addressed.
Numerous industry working groups have convened to discuss and create standards, guidelines, and best practices for securing networked medical devices across the healthcare industry. This work is essential and will move the industry in the right direction, but there are security decisions that can be made today to protect devices and the sensitive data they transmit. Certain security approaches, such as encryption and authentication, will be part of whatever standard emerges from the working groups.
Secure IoT medical devices should contain costs for both industry professionals and patients. Today, we have much more data for medical research and patient monitoring to implement more effective risk prevention plans - in this context, better device safety means better healthcare.
Sensoworks IIoT Platform allows you to acquire data from any medical device - whether it is a “wearable” device such as a glucometer, or a diagnostic device such as an X-ray or ultrasound system. The purpose is to monitor both the operating status of the device and to analyse any tampering with it from a security point of view.
The platform, therefore, allows you to monitor in real time the operating status of the devices and the occurrence of any security problems due to tampering or attacks (cyber security), by notifying the control centre of the onset of these phenomena.
Sensing the future is our way to help our customers achieve impressive results.
We are a highly innovative company that exploits the most advanced technologies to monitor, predict and control complex data from different sources in real-time.
Website: https://test2.hueval.com
LinkedIn: https://www.linkedin.com/company/sensoworks
The four mosquito-borne dengue virus serotypes (DENV1–DENV4) cause a high burden of disease throughout the tropical and sub-tropical regions of the world. Nevertheless, their precise epidemiological history in Africa - including when and where they originated and were distributed during the 20th century - remains unclear, stressing the need for One Health focused research.
The Sensoworks IIoT Platform (Intelligent Internet of Things) analyses a set of clinical data from a biochemical sensor (patch) for continuous patient monitoring.
The method is similar to Continuous Glucose Monitoring, which provides - at very short intervals -the values detected in the subcutaneous interstitial fluid, recording the variation of the parameters.
The biological element interacts with the substrate to be analysed and, thanks to the transduction system (sensor), it converts the biochemical response into an electrical signal.
Leveraging wireless radio frequency technology, the continuous monitoring system is equipped with a small and light sensor connected to a transmitter, which sends the data detected by the sensor to the patient's smartphone on regular intervals during the 24 hours.
The smartphone sends data to the Sensoworks IIoT Platform in real-time, communicating the detected parameters. These parameters will be displayed and analysed by a health worker, in order to monitor the possible evolution of the infection.
In the hypothesis of a patient who develops the disease in the days following the return from a tropical country, the Sensoworks IIoT Platform will allow the healthcare professional to identify the patient for tracking purposes (contact tracing).
The Sensoworks IIoT Platform, therefore, acts as a centralised tool for the management of the eventual evolution of the disease, for all patients under observation to whom the biochemical sensor has been applied, effectively constituting a real centre for the management and tracking of a possible epidemic.
Sensing the future is our way to help our customers achieve impressive results.
We are a highly innovative company that exploits the most advanced technologies to monitor, predict and control complex data from different sources in real-time.
Website: https://test2.hueval.com
